Webinar

Changing Antibody Discovery through Lab Automation Q&A

View

Peer-Reviewed Publication

Science: Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study

View

Peer-Reviewed Publication

Science: Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern

View

Peer-Reviewed Publication

Nature: Multivalency Transforms SARS-CoV-2 Antibodies into Ultrapotent Neutralizers

View

Peer-Reviewed Publication

Nature Medicine: A candidate antibody drug for prevention of malaria

View

Peer-Reviewed Publication

Nature Scientific Reports: High‑throughput analysis system of interaction kinetics for data‑driven antibody design

View

Peer-Reviewed Publication

Nature: A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies

View

Peer-Reviewed Publication

Cell Reports: Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium

View

Peer-Reviewed Publication

Cell Reports: LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

View

Presentation

Presentation: Redefining High-Throughput SPR: The Carterra Vega™ Platform

View

Pre-Print Publication

Generation of T cells with reduced off-target cross-reactivities by engineering co-signalling receptors

View

Pre-Print Publication

Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38

View

Peer-Reviewed Publication

Absolute concentration estimation of COVID- 19 convalescent and post-vaccination IgG antibodies

View

Peer-Reviewed Publication

A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developability

View